Literature DB >> 12668371

Unexplained fatigue syndromes in a multinational primary care sample: specificity of definition and prevalence and distinctiveness from depression and generalized anxiety.

Petros Skapinakis1, Glyn Lewis, Venetsanos Mavreas.   

Abstract

OBJECTIVE: The authors investigated whether narrow definitions of unexplained fatigue syndromes that require additional minor somatic symptoms are more strongly associated with psychiatric morbidity than wider ones.
METHOD: This was a secondary analysis of the World Health Organization Collaborative Project on Psychological Problems in General Health Care. A total of 5,438 primary care patients from 14 countries were assessed with the Composite International Diagnostic Interview.
RESULTS: The prevalence of fatigue syndromes fell from 7.99 to 1.69 as somatic criteria were added. Patients with depression or anxiety were more likely to report unexplained fatigue, but this association was stronger for definitions of unexplained fatigue with more somatic criteria.
CONCLUSIONS: Definitions of unexplained fatigue syndromes that require more somatic criteria selected more patients with psychiatric disorders in this culturally diverse sample. These findings might have implications for the revision of existing international diagnostic criteria for neurasthenia or chronic fatigue syndrome.

Entities:  

Mesh:

Year:  2003        PMID: 12668371     DOI: 10.1176/appi.ajp.160.4.785

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  21 in total

1.  Aetiology of fatigue in Sri Lanka and its overlap with depression.

Authors:  Harriet A Ball; Athula Sumathipala; Sisira H Siribaddana; Yulia Kovas; Nick Glozier; Peter McGuffin; Matthew Hotopf
Journal:  Br J Psychiatry       Date:  2010-08       Impact factor: 9.319

2.  Specific treatment of residual fatigue in depressed patients.

Authors:  Humberto Marin; Matthew A Menza
Journal:  Psychiatry (Edgmont)       Date:  2004-09

3.  Prolonged fatigue is associated with sickness absence in men but not in women: prospective study with 1-year follow-up of white-collar employees.

Authors:  Corné A M Roelen; Willem van Rhenen; Johan W Groothoff; Jac J L van der Klink; Ute Bültmann
Journal:  Int Arch Occup Environ Health       Date:  2013-02-22       Impact factor: 3.015

4.  Fatigability in basic indoor mobility in nonagenarians.

Authors:  Minna Mänty; Anette Ekmann; Mikael Thinggaard; Kaare Christensen; Kirsten Avlund
Journal:  J Am Geriatr Soc       Date:  2012-06-15       Impact factor: 5.562

5.  IgM-mediated autoimmune responses directed against anchorage epitopes are greater in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) than in major depression.

Authors:  Michael Maes; Ivana Mihaylova; Marta Kubera; Jean-Claude Leunis; Frank N M Twisk; Michel Geffard
Journal:  Metab Brain Dis       Date:  2012-05-22       Impact factor: 3.584

6.  Fatigue as prognostic risk marker of mental sickness absence in white collar employees.

Authors:  C A M Roelen; M W Heymans; W van Rhenen; J W Groothoff; J W R Twisk; U Bültmann
Journal:  J Occup Rehabil       Date:  2014-06

7.  Gene Expression Factor Analysis to Differentiate Pathways Linked to Fibromyalgia, Chronic Fatigue Syndrome, and Depression in a Diverse Patient Sample.

Authors:  Eli Iacob; Alan R Light; Gary W Donaldson; Akiko Okifuji; Ronald W Hughen; Andrea T White; Kathleen C Light
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-01       Impact factor: 4.794

8.  A systematic review of chronic fatigue syndrome: don't assume it's depression.

Authors:  James P Griffith; Fahd A Zarrouf
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

9.  Prognosis of fatigue and functioning in primary care: a 1-year follow-up study.

Authors:  Iris Nijrolder; Daniëlle A W M van der Windt; Henriëtte E van der Horst
Journal:  Ann Fam Med       Date:  2008 Nov-Dec       Impact factor: 5.166

10.  Chronic fatigue syndrome in the emergency department.

Authors:  Christian R Timbol; James N Baraniuk
Journal:  Open Access Emerg Med       Date:  2019-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.